Welcome to Elicera's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders.

If you need more information or have any questions, please contact Jamal El-Mosleh, CEO.

Phone: +46(0)703 31 90 51

Press Releases

All Press Releases

Corporate Governance

The following sections contain information that are relevant for Elicera's corporate governance.

Articles of AssociationGeneral MeetingBoardManagementAuditorCertified Adviser

The Share

Elicera Therapeutics is listed on Nasdaq First North Growth Market. The company has issued one class of shares and the total number of shares amounts to 19 782 000.

Read about the Share

Financial Reports

Front cover of an Elicera report
Latest report:
August 29, 2023
Q2 report 2023

Financial Calendar

See the calendar

Analyst Coverage

Read the latest analysis on Elicera here:

All analyses